Nico.Lab B.V.
About Nico.Lab B.V.
Nico.Lab B.V. is a Dutch health technology company at the forefront of applying artificial intelligence to acute stroke care. Their flagship product, StrokeViewer, is an FDA-cleared and CE-marked AI-powered clinical decision support system designed to provide physicians with rapid and accurate analysis of imaging biomarkers in emergency settings. The platform leverages advanced algorithms to process CT and MR scans, enabling the swift detection of critical conditions such as large vessel occlusions (LVO) and intracerebral hemorrhage (ICH), quantification of brain tissue at risk, and assessment of collateral circulation, all within minutes of a patient’s scan.
StrokeViewer is engineered to streamline the entire stroke workflow by integrating human and artificial intelligence. This cloud-based solution facilitates automated image analysis, mobile diagnostic viewing, and collaborative tools for clinicians, thereby accelerating diagnosis and enabling more informed treatment decisions. The system’s ability to provide vital information quickly and efficiently is paramount in stroke management, where timely intervention can significantly improve patient outcomes and minimize long-term disability. Nico.Lab’s mission is to empower physicians globally to deliver the right treatment to every patient in time, and they are also exploring expansion into other acute disease areas such as heart attack and abdominal traumas.
Focus Areas
Business Intelligence
| Key Investors | Canaccord Genuity Australia, European Innovation Council (EIC Fund), Holland in the Valley, Ellerston Capital, Soul Patts, Royal Philips |
| Partnerships | AI Advance (Australia and New Zealand), Royal Philips, Health New Zealand, University of Otago, Human Bytes (Nordic countries), Harrison.ai, Veritas Biomedical (Taiwan), Google Cloud |
| Technology | Cloud-based, AI algorithms, machine learning (TensorFlow), Google Cloud, cloud-native architecture, DICOM/PACS integration, mobile diagnostic image viewing, telemedicine collaboration tools |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
Nico.Lab's solutions, particularly StrokeViewer, are designed to empower physicians by providing rapid, accurate, and clinically validated AI insights directly within their workflow. This means faster diagnosis and treatment decisions for acute stroke patients, potentially leading to improved outcomes and reduced disability. The mobile and cloud-based access allows for remote review and collaboration, enhancing flexibility and efficiency in time-critical emergency settings. The expansion into Aortic Dissection and Pulmonary Embolism further consolidates acute care imaging and triage on a single platform, reducing the need to switch between multiple systems.
Nico.Lab's platform is built for seamless integration with existing hospital IT infrastructure and PACS, requiring no additional hardware installation. It supports secure DICOM transfers and can utilize Google Cloud VPN for legacy systems. The company also collaborates with third-party AI systems to expand its clinical offerings beyond stroke, providing a unified platform for imaging, communication, and AI.
Reviews & Opinions
Videos
News, demos, and interviews about Nico.Lab B.V..
Videos load interactively. If none appear, search YouTube for Nico.Lab B.V. →
Press & Coverage
Frequently Asked Questions
Comparisons
For a physician evaluating AI tools for acute stroke management, HALO by Nico.Lab B.V. and Viz CTP by Viz.ai offer distinct strengths. HALO specializes in the rapid detection of large vessel occlusions (LVO) and intracerebral hemorrhage (ICH), providing timely notifications and facilitating the evaluation of brain vasculature on CT angiograms. It excels in its focused […]
When choosing between HALO by Nico.Lab B.V. and ContaCT by Viz.ai, physicians should consider their primary need: rapid, focused stroke detection and quantification, or a broader AI-powered care coordination platform. HALO excels in the acute stroke setting, specifically designed for the rapid detection of large vessel occlusions (LVO) and intracerebral hemorrhage (ICH), including volume quantification. […]
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]